Objective. Bronchopulmonary carcinosarcoma is a very rare tumor and the prognosis of patients with carcinosarcoma is assessed as unfavourable. The problems concerning diagnosis, therapy, and prognosis after resection treatment are discussed with reference to our seven cases and with consideration of the pertinent literature.
Methods. The retrospective data of seven patients with pulmonary carcinosarcoma were analysed. All were staged postoperatively according to the international TNM staging system. The diagnosis was verified by immunohistochemical investigation. The prognosis of the patients with carcinosarcoma was compared with the prognosis of patients with non-small cell carcinoma of the lung.
Results. Whether lung resection is the treatment of choice for these patients is of no relevance, because in most cases the preoperative diagnosis is incomplete, as only one component of the tumor, namely the epithelial one, is found in the biopsy specimen. The complete and correct diagnosis in five of the seven cases was not made before the resection had been performed and in the remaining two patients it was only made when tumor recurrence or metastases occurred. The prognosis of patients with carcinosarcoma of the lung is assessed to be comparable to that of patients with other pulmonary carcinoma: in this study survival times ranged from only 3 months (T2N3) to 4 years 6 months (T3N1). The causes of death of the patients with carcinosarcoma were local recurrence in four patients and metastases at distant sites in two. Two recurrent tumors as well as the metastases consisted only of the sarcoma component of the primary tumor histologically,
Introduction
The first reported case of carcinosarcoma in the lung is attributed to Kika [4, 151. According to the WHO [23] carcinosarcomas are subdivided into two groups: the embryonic carcinosarcomas (pulmonary blastomas, embryomas) and other than embryonic carcinosarcomas. So far nearly 100 pulmonary blastomas and 80 cases of carcinosarcomas have been described in the literature_ The carcinosarcoma is defined as a bidirectional tumor containing a mixture of carcinomatous and sarcomatous components [5] .
There is agreement that the differentiation of carcinosarcoma is very difficult, and it is rarely diagnosed preoperatively [14, 21, 22] . The prognosis of patients with pulmonary carcinosarcoma is generally assessed as unfavorable [6, 13, 21] , due to the marked tendency of the tumor to metastasize at distant sites and the high rate of local recurrence [13, 21] . In our institution we have experience of seven cases of pulmonary carcinosarcoma. The aim of this report is to report on the problems of the diagnosis of these tumors and to evaluate possible prognostic factors.
Patients and methods
Between 1975 and 1995, seven patients with pulmonary carcinosarcoma were treated surgically at our unit. The retrospective data from these patients were analysed. All were staged postoperatively according to the international TNM staging system.
After the preoperative diagnosis "non-small cell carcinoma" by histological or cytological examination of specimens obtained by bronchoscopy or percutaneou s needle biopsy, the following investigations were undertaken to confirm functional and anatomical operability: the patient's general condition was assessed by exercise electrocardiogram (ECG) and body plethysmography. In patients with cardiac history, radioisotopic imaging of the left ventricle and/or left heart catheterization were performed. Limited respiratory function led us to make perfuslon and ventilation scans of the lung preoperatively. The resectability of the tumors was proven by radiographic and endoscopic methods including rigid bronchoscopy with biopsies of the carinas. To visualize the mediastinal N-status, pulmonary tomography was performed until 1984, from then on computed tomographic (CT) scans were available.
Mediastinoscopy was performed if signs of mediastinal lymph node enlargement in the N3 region were seen, because we considered N2 disease to be amenable to curative resection treatment. We began a study of mnltimodal treatment of N2 disease of non-small cell carcinomas in 1994, since then mediastinoscopy has become routine procedure if the CT scan reveals enlarged lymph nodes in the N2 region. Metastatic spread was ruled out with abdominal ultrasound, isotope bone scan, CT scanning of the brain, and CT scanning of the adrenal glands. Mediastinal lymph node dissection has been routinely included in the resection treatment of non-small cell carcinoma, before 1986 as a sampling dissection and since then as extensive dissection. All patients with involved mediastinal lymph nodes received postoperative percutaneous radiotherapy to the mediastinum.
If the postoperative histological examination revealed carcinomatous and sarcomatous components in the tumor, immunohistochemical examination was performed with a monoclonal cytokeratin antibody linking to most of the known cytokeratins IAE-1 and AE-2) i and anti-vimentin (monoclonal mouse antibody) .
Resuits
Five of the seven patients with pulmonary carcinosarcoma were men and two were women. The age range was 35-67
Hybritech, San Diego, Calif., USA 2 Boehringer, Mannheim, Germany Squamous cell carcinoma Myo-chondrosarcoma years. Table 1 shows age, sex and tumor location of the individual patients in the patient population. The preoperative bronchoscopy revealed endobronchial non-small cell carcinoma in three patients only. In two cases it could be seen in the left main bronchus (T3 tumor) and in one case in the segmental bronchus 2 of the right lung (T3 tumor because of infiltration of the parietal pleura, in case 1). The four other tumors had an even more peripheral location. Two of these patients underwent diagnostic thoracotomy with the diagnosis "tumor of unknown dignity". The diagnosis "non-small cell carcinoma" was made in the other two patients by bronchial lavage and percutaneous puncture, respectively.
In the seven cases we report on the mesenchymal component of the carcinosarcoma was never diagnosed preoperatively. The correct diagnosis carcinosarcoma was obtained by histological examination in five cases postoperatively. In two of the seven cases the complete diagnosis was made following local recurrence of the tumor or metastases at distant sites, causing re-evaluation of the resected lung tissue (cases 5 and 6). Table 2 shows the epithelial and mesenchymal components of our series of carcinosarcomas.
On CT scan two patients were suspected of having mediastinal lymph node metastases in the N2 region, and one in the N3 region. We performed a mediastinoscopy in the patient with suspected N3 disease. Because of bleeding due to an injury of the brachiocephalic trunc, a median sternotomy had to be performed for hemostasis, and resection of the right lower lobe and mediastinal lymph node dissec- tion were carried out during the same operation. The lymph node metastases consisted of the carcinomatous component of the tumor in two cases (N1 and N2, respectively), of the sarcomatous component in one case (N3), and of both tumorous components in one case (N2). We found four T3 tumors in our patient population. Two of these tumors were in the main bronchus less than 2 cm distal to the carina and two were invading the parietal pleura. The modes of resection treatment were lobectomy in four cases and pneumonectomy in three. Two patients underwent chest wall resection (cases l and 2). In addition, mediastinal lymph node dissection was accomplished. The lymph node dissection was performed in a sampling manner in cases 1-3 (1976-1986)and as extensive dissection in cases 4-7 (1989-1993) . Out of the seven operations we regarded six as potentially curative, and one (T2N3) as an incomplete resection. In our series we observed survival times of only 8 months (T3N0) up to 4 years and 6 months (T3N1) after potentially curative resection treatment (Table 3 ). The causes of death were local recurrence of the tumor in four patients and metastases at distant sites in two (Table 3) . One patient is alive and presently free from tumor recurrence. Two recurrent tumors could not be examined histologically. The remaining two recurrent tumors and the metastases in two patients consisted of the sarcoma component of the primary tumor only (Table 3) . 0.3%) between 1975 and 1995. In agreement, Diaconita reported eight cases among 3000 malignant pulmonary tumors [71. Carcinosarcomas are basically tumors of older people [5, 8, 10] , and 42 of 50 cases described by CohenSalmon et al. (1985) occurred in men [4] . The age distribution of our patients is not in accordance with the literature, where only 4% were less than 40 years of age [3] . Three of our patients were in the 4th and four in the 7th decade of life (Table 1) .
Diagnosis
Carcinosarcoma is defined to be a biphasic malignant tumor. From the first description of a carcinosarcoma by Kika in 1908 to the early 1980s, diagnosis was only made by conventional light microscopy and staining until Huszar and colleagues (1984) introduced immunohistological staining and immunofluorescent microscopy [12] . Carcinomatous and sarcomatous tumor formation can thus be readily distinguished from each other by cytokeratin and vimentin antibodies. The differences in the reaction of earcinosarcomas to these tumor markers is the basis for the most recent definition of carcinosarcomas. According to this definition, carcinosarcoma of the lung is a tumor comprising both malignant epithelial and malignant mesenchymal components in which features of epithelial differentiation may not be demonstrable immunohistochemically in the spindle cell component. Otherwise, these tumors are to be classified as carcinomas with spindle-cell differentiation [21] .
The carcinosarcoma is rarely diagnosed preoperatively. If the tumor is located centrally, in most cases biopsies show only one component, and peripheral tumors can often not be reached endoscopically. In a case described by Ishizuka et al. [14] the diagnosis of a carcinosarcoma was even made by sputum cytology. Cohen-Salmon et al. [4] and Cabarcos et al.
[3] detected a carcinosarcoma by transthoracal needle biopsy. According to Ishizuka [14] the correct diagnosis was established preoperatively in only 3 of 48 cases reviewed. In this series carcinosarcoma was diagnosed by postoperative histological examination in five of our seven cases. In two of these cases the correct diagnosis was found following local recurrence of the tumor or metastases at distant sites, causing re-evaluation of the resected lung. No additional contribution can be made preoperatively establishing the correct diagnosis by means of imaging techniques, e.g. CT scan [10, 20] . There is also no specific tumor marker available for carcinoma [21] .
Discussion

Epidemiology
Carcinosarcoma of the lung is extremely rare. Among our patients we found seven cases out of 2400 patients (i.e.
Histology
The most common epithelial component of the carcinosarcoma is the squamous cell carcinoma (69%); adenocarcinoma is present in 20% and undifferentiated large cell carcinoma in 11% [3] . Thus far a small cell carcinoma corn-ponent has been only described in one case, by Tsubota and colleagues [22] . We also found such an epithelial component in one tumor ( Table 2 ). The most frequent stromal component is the spindle cell component, classically referred to as fibrosarcoma [1, 5] . At times, osteosarcoma, chondrosarcoma, leiomyosarcoma [19] , and rhabdomyosarcoma [18] may be found.
The histogenesis of carcinosarcomas remains unclear. Attempts have been made in the past to explain the histogenesis and several theories have been proposed. Dail (1994) concludes that a cell, once it becomes tumorous, can dip into its heritage pool of totipotentiality and can differentiate into diverse cell lines even within a single tumor. Therefore the theories of histogenesis are no longer necessary once one accepts this totipotentiality [5] .
Treatment and prognosis
Whether resection treatment is the treatment of choice for pulmonary carcinosarcoma does not need to be discussed, because in most cases the preoperative diagnosis is incomplete and only one component of the tumor, mostly the epithelial one, is known. The prognosis of patients with carcinosarcoma of the lung is assessed as unfavorable only on the grounds of the small number of cases described [6, 13, 21] . Davis et al. [6] reported a median survival time of 12 months in 15 patients after potentially curative resection treatment, whereas the median survival time of five patients reported by Ishida et al. [13] was only 9 months. Reviewing the literature [1, 3, 4, 6] one can find great differences in survival times. Most of the data do not define the tumor stage, and therefore conclusions on the prognosis are difficult to achieve.
In order to compare the prognosis of the carcinosarcoma with other malignant pulmonary tumors, the median survival times and 5-year survival rates of patients with adenocarcinoma and squamous cell carcinoma of the lung, resected from 1975 to 1994 at our unit, are shown in Table 4_ Only the same tumor stages, that are comparable with the tumor stages of the carcinosarcomas, are presented. Because of the small number of cases of carcinosarcomas a statistical analysis could not be performed, however, it seems that the prognosis of these different tumors is similar. The causes of death of patients with carcinosarcoma were tumor recurrence of metastases at distant sites. Two recurrent tumors could not be examined histologically, the remaining two recurrent tumors, as well as the metastases, consisted only of the sarcomatous component of the primary tumor. One might suggest that the prognosis in car- cinosarcoma of the lung is determined by the malignant mesenchymal component of the tumor. In general patients with soft tissue sarcoma have a poor prognosis due to the tendency of these tumors to recur locally and metastasize hematogenously early in the course of the disease. This specific behavior is independent of the pathological designation and tissue of the origin and independent of the anatomical site of the lesion [16] . The most important determinant of biological behavior and the ultimate outcome is the histological grade [16] . Nowadays the therapy of soft tissue sarcoma is multimodal. Surgical resection treatment is the most important part of therapy. In addition, radiation is well established and effective in the treatment of patients with soft tissue sarcomas. Even if the sarcoma is resected incompletely and the resection margins show residual tumor on microscopy, the rate of local recurrence can be reduced to about 15% by local radiation therapy [2] . Thus the combination of resection treatment and external radiation is thought to be the standard therapy of G II and GIII soft tissue sarcoma at present. Chemotherapeutic agents, e.g. doxorubicin, adriamycin, ifosfamide and dacarbazine, are known to be effective in the treatment of soft tissue sarcomas as well [17] . If distant metastases of soft tissue sarcomas occur, a combination chemotherapy is indicated. The overall response rate after systemic treatment of advanced tumors is estimated to be 40%. The appropriate place for adjuvant chemotherapy in the management of soft tissue sarcomas has not yet been clearly defined [9] , patients with G III diseases may profit from chemotherapy, however.
In conclusion, the prognosis of the patients with pulmonary carcinosarcomas seems to depend on the sarcoma component of the tumor. For this reason, generally accepted modes of therapy for soft tissue sarcomas should be adopted in the treatment of patients with pulmonary carcinosarcoma.
